Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Statin therapy enhances vascular health through epigenetic mechanisms

Nature Cardiovascular Research volume 2, pages 502–503 (2023)Cite this article

Subjects

Our study demonstrates that statins improve endothelial function and vascular health by inhibiting the epigenetic activation of the YAP–SOX9 signaling axis and subsequently preventing endothelial-to-mesenchymal transition in conditions associated with an increased risk of cardiovascular disease, such as type 2 diabetes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Epigenetic alterations induced by simvastatin treatment in iPSC-ECs.

References

  1. Chou, R., Dana, T., Blazina, I., Daeges, M. & Jeanne, T. L. Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA 316, 2008–2024 (2016). A review article that presents the use of statins for reducing CVD risk.

    Article  PubMed  Google Scholar 

  2. Oesterle, A., Laufs, U. & Liao, J. K. Pleiotropic effects of statins on the cardiovascular system. Circ. Res. 120, 229–243 (2017). A review article that discusses the pleiotropic effects of statins.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kovacic, J. C. et al. Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 73, 190–209 (2019). A review article that presents the role of EndMT in CVD.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213–1218 (2013). This paper reports the establishment of ATAC–seq technology.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Nishiga, M., Liu, C., Qi, L.S. & Wu, J.C. The use of new CRISPR tools in cardiovascular research and medicine. Nat. Rev. Cardiol. 19, 505–521 (2022). A review article that presents recent advancements in CRISPR technologies for CVD.

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Liu, C. et al. Statins improve endothelial function via suppression of epigenetic-driven EndMT. Nat. Cardiovas. Res. https://doi.org/10.1038/s44161-023-00267-1 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Statin therapy enhances vascular health through epigenetic mechanisms. Nat Cardiovasc Res 2, 502–503 (2023). https://doi.org/10.1038/s44161-023-00274-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-023-00274-2

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing